199 related articles for article (PubMed ID: 21460389)
21. Illness absences among beryllium sensitized workers.
Watkins JP; Ellis ED; Girardi DJ; Cragle DL; Richter BS
Am J Public Health; 2014 Nov; 104(11):e165-9. PubMed ID: 25211750
[TBL] [Abstract][Full Text] [Related]
22. Association between IL-1A single nucleotide polymorphisms and chronic beryllium disease and beryllium sensitization.
McCanlies EC; Yucesoy B; Mnatsakanova A; Slaven JE; Andrew M; Frye BL; Schuler CR; Kreiss K; Weston A
J Occup Environ Med; 2010 Jul; 52(7):680-4. PubMed ID: 20595916
[TBL] [Abstract][Full Text] [Related]
23. Beryllium sensitization and lung function among former workers at the Nevada Test Site.
Rodrigues EG; McClean MD; Weinberg J; Pepper LD
Am J Ind Med; 2008 Jul; 51(7):512-23. PubMed ID: 18459143
[TBL] [Abstract][Full Text] [Related]
24. HLA-DPB1 and chronic beryllium disease: a HuGE review.
McCanlies EC; Kreiss K; Andrew M; Weston A
Am J Epidemiol; 2003 Mar; 157(5):388-98. PubMed ID: 12615603
[TBL] [Abstract][Full Text] [Related]
25. Beryllium particulate exposure and disease relations in a beryllium machining plant.
Kelleher PC; Martyny JW; Mroz MM; Maier LA; Ruttenber AJ; Young DA; Newman LS
J Occup Environ Med; 2001 Mar; 43(3):238-49. PubMed ID: 11285872
[TBL] [Abstract][Full Text] [Related]
26. The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization.
McCanlies EC; Ensey JS; Schuler CR; Kreiss K; Weston A
Am J Ind Med; 2004 Aug; 46(2):95-103. PubMed ID: 15273960
[TBL] [Abstract][Full Text] [Related]
27. Genetic determinants of sensitivity to beryllium in mice.
Tarantino-Hutchison LM; Sorrentino C; Nadas A; Zhu Y; Rubin EM; Tinkle SS; Weston A; Gordon T
J Immunotoxicol; 2009 Jun; 6(2):130-5. PubMed ID: 19589099
[TBL] [Abstract][Full Text] [Related]
28. Low prevalence of chronic beryllium disease among workers at a nuclear weapons research and development facility.
Arjomandi M; Seward J; Gotway MB; Nishimura S; Fulton GP; Thundiyil J; King TE; Harber P; Balmes JR
J Occup Environ Med; 2010 Jun; 52(6):647-52. PubMed ID: 20523233
[TBL] [Abstract][Full Text] [Related]
29. Genetic and exposure risks for chronic beryllium disease.
Maier LA
Clin Chest Med; 2002 Dec; 23(4):827-39. PubMed ID: 12516537
[TBL] [Abstract][Full Text] [Related]
30. TNF-alpha polymorphisms in chronic beryllium disease and beryllium sensitization.
McCanlies EC; Schuler CR; Kreiss K; Frye BL; Ensey JS; Weston A
J Occup Environ Med; 2007 Apr; 49(4):446-52. PubMed ID: 17426528
[TBL] [Abstract][Full Text] [Related]
31. Associations of Metrics of Peak Inhalation Exposure and Skin Exposure Indices With Beryllium Sensitization at a Beryllium Manufacturing Facility.
Virji MA; Schuler CR; Cox-Ganser J; Stanton ML; Kent MS; Kreiss K; Stefaniak AB
Ann Work Expo Health; 2019 Oct; 63(8):856-869. PubMed ID: 31504146
[TBL] [Abstract][Full Text] [Related]
32. Metal-specific CD4+ T-cell responses induced by beryllium exposure in HLA-DP2 transgenic mice.
Falta MT; Tinega AN; Mack DG; Bowerman NA; Crawford F; Kappler JW; Pinilla C; Fontenot AP
Mucosal Immunol; 2016 Jan; 9(1):218-28. PubMed ID: 26129650
[TBL] [Abstract][Full Text] [Related]
33. Immunogenetic factors in beryllium sensitization and chronic beryllium disease.
Weston A; Snyder J; McCanlies EC; Schuler CR; Andrew ME; Kreiss K; Demchuk E
Mutat Res; 2005 Dec; 592(1-2):68-78. PubMed ID: 16054169
[TBL] [Abstract][Full Text] [Related]
34. Function associated transforming growth factor-beta gene polymorphism in chronic beryllium disease.
Gaede KI; Amicosante M; Schürmann M; Fireman E; Saltini C; Müller-Quernheim J
J Mol Med (Berl); 2005 May; 83(5):397-405. PubMed ID: 15750822
[TBL] [Abstract][Full Text] [Related]
35. Beryllium lymphocyte proliferation test surveillance identifies clinically significant beryllium disease.
Mroz MM; Maier LA; Strand M; Silviera L; Newman LS
Am J Ind Med; 2009 Oct; 52(10):762-73. PubMed ID: 19681064
[TBL] [Abstract][Full Text] [Related]
36. Beryllium sensitivity is linked to HLA-DP genotype.
Wang Z; Farris GM; Newman LS; Shou Y; Maier LA; Smith HN; Marrone BL
Toxicology; 2001 Aug; 165(1):27-38. PubMed ID: 11551429
[TBL] [Abstract][Full Text] [Related]
37. Beryllium-induced lung disease exhibits expression profiles similar to sarcoidosis.
Li L; Silveira LJ; Hamzeh N; Gillespie M; Mroz PM; Mayer AS; Fingerlin TE; Maier LA
Eur Respir J; 2016 Jun; 47(6):1797-808. PubMed ID: 27103383
[TBL] [Abstract][Full Text] [Related]
38. HLA class II DPB1 and DRB1 polymorphisms associated with genetic susceptibility to beryllium toxicity.
Rosenman KD; Rossman M; Hertzberg V; Reilly MJ; Rice C; Kanterakis E; Monos D
Occup Environ Med; 2011 Jul; 68(7):487-93. PubMed ID: 21186201
[TBL] [Abstract][Full Text] [Related]
39. Beryllium-Induced Hypersensitivity: Genetic Susceptibility and Neoantigen Generation.
Fontenot AP; Falta MT; Kappler JW; Dai S; McKee AS
J Immunol; 2016 Jan; 196(1):22-7. PubMed ID: 26685315
[TBL] [Abstract][Full Text] [Related]
40. Beryllium disease among construction trade workers at Department of Energy nuclear sites.
Welch LS; Ringen K; Dement J; Bingham E; Quinn P; Shorter J; Fisher M
Am J Ind Med; 2013 Oct; 56(10):1125-36. PubMed ID: 23794247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
